Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-tubulin is a highly conserved globular protein that forms heterodimers with alpha-tubulin. These dimers are the building blocks for microtubules—dynamic cylindrical polymers that are essential components of the eukaryotic cytoskeleton. Microtubules provide structural support, serve as tracks for intracellular transport, and play critical roles in chromosome segregation during cell division. The dynamic behavior of microtubules depends on GTP binding and hydrolysis by the beta subunit; this property underlies their rapid assembly/disassembly cycles crucial for cellular functions such as mitosis. Multiple genes encode different β-tubulin isotypes with tissue-specific expression patterns. Some isotypes are overexpressed in cancers and contribute to chemotherapy resistance. Drugs targeting β-tubulin disrupt microtubule dynamics—either stabilizing them against depolymerization or promoting disassembly—which can halt proliferation especially in rapidly dividing tumor cells but also cause side effects due to impacts on normal tissues. Alterations in β-tubulin function have been implicated not only in cancer but also neurodegenerative diseases and congenital disorders known as tubulinopathies.[1][2][3][5]
Inhibition of microtubule polymerization or depolymerization, leading to cell cycle arrest and apoptosis in rapidly dividing cells[5][6] - Stabilization of microtubules, preventing their disassembly and thus blocking mitosis (e.g., paclitaxel)[6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-tubulin subunit of microtubules (β-tubulin).